Warfarin sodium remains a highly effective therapy for prevention of thromboembolic strokes in common clinical situations, especially atrial fibrillation.
1-4 This protective effect of anticoagulation is in part offset by the risk of hemorrhagic complications, particularly intracerebral hemorrhage (ICH), the deadliest stroke subtype. Because of the poor outcome associated with warfarin-related ICH (warfarin-ICH), this complication has a large effect on the clinical decision of whether to administer anticoagulants.